References
- Semenza GL. Regulation of oxygen homeostasis by hypoxia-inducible factor-1. Physiology 2009;24:97–106.
- Varela-Nallar L, Rojas-Abalos M, Abbott AC, Moya EA, Iturriaga R, Inestrosa NC. Chronic hypoxia induces the activation of the Wnt/beta-catenin signaling pathway and stimulates hippocampal neurogenesis in wild-type and APPswe-PS1ΔE9 transgenic mice in vivo. Front Cell Neurosci 2014;8:17.
- Yu AY, Shimoda LA, Iyer NV, et al. Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1alpha. J Clin Invest 1999;103:691–6.
- Kim YM, Barnes EA, Alvira CM, Ying L, Reddy S, Cornfield DN. Hypoxia-inducible factor-1alpha in pulmonary artery smooth muscle cells lowers vascular tone by decreasing myosin light chain phosphorylation. Circ Res 2013;112:1230–3.
- Parker LH, Schmidt M, Jin SW, et al. The endothelial-cell-derived secreted factor Egfl7 regulates vascular tube formation. Nature 2004;428:754–8.
- Lee JH, Gao Z, Ye J. Regulation of 11beta-HSD1 expression during adipose tissue expansion by hypoxia through different activities of NF-κB and HIF-1α. Am J Physiol Endocrinol Metab 2013;304:E1035–41.
- Campagnolo L, Leahy A, Chitnis S, et al. Egfl7 is a chemoattractant for endothelial cells and is up-regulated in angiogenesis and arterial injury. Am J Pathol 2005;167:275–84.
- Baek KJ, Cho JY, Rosenthal P, Alexander LE, Nizet V, Broide DH. Hypoxia potentiates allergen induction of HIF-1alpha, chemokines, airway inflammation, TGF-beta1, and airway remodeling in a mouse model. Clin Immunol 2013;47:27–37.
- Huang Y, Hickey RP, Yeh JL, et al. Cardiac myocyte-specific HIF-1alpha deletion alters vascularization, energy availability, calcium flux, and contractility in the normoxic heart. FASEB J 2004;18:1138–40.
- Fujisaka S, Usui I, Ikutani M, et al. Adipose tissue hypoxia induces inflammatory M1 polarity of macrophages in an HIF-1alpha-dependent and HIF-1alpha-independent manner in obese mice. Diabetologia 2013;56:1403–12.
- Gustavsson M, Mallard C, Vannucci SJ, Wilson MA, Johnston MV, Hagberg H. Vascular response to hypoxic preconditioning in the immature brain. J Cereb Blood Flow Metab 2007;27:928–38.
- Allport JR, Lim YC, Shipley JM, et al. Neutrophils from MMP-9 or neutrophil elastase-deficient mice show no defect in transendothelial migration under flow in vitro. J Leukoc Biol 2002;71:821–8.
- Ando H, Natsume A, Iwami K, et al. A hypoxia-inducible factor (HIF)-3alpha splicing variant, HIF-3alpha4 impairs angiogenesis in hypervascular malignant meningiomas with epigenetically silenced HIF-3alpha4. Biochem Biophys Res Commun 2013;433:139–44.
- Kuhnert F, Mancuso MR, Hampton J, et al. Attribution of vascular phenotypes of the murine Egfl7 locus to the microRNA-126. Development 2008;135:3989–93.
- Lian LH, Jin Q, Song SZ, et al. Ginsenoside Rh2 downregulates LPS-induced NF-κB activation through inhibition of TAK1 phosphorylation in RAW 264.7 murine macrophage. Evid Based Complement Alternat Med 2013;13:646–728.
- Cai Z, Luo W, Zhan H, Semenza GL. Hypoxia-inducible factor 1 is required for remote ischemic preconditioning of the heart. Proc Natl Acad Sci USA 2013;110:17462–7.
- Soncin F, Mattot V, Lionneton F, et al. VE–statin, an endothelial repressor of smooth muscle cell migration. EMBO J 2003;22:5700–11.
- Rouschop KM, Dubois LJ, Keulers TG, et al. PERK/eIF2alpha signaling protects therapy resistant hypoxic cells through induction of glutathione synthesis and protection against ROS. Proc Natl Acad Sci USA 2013;110:4622–727.
- Fitch MJ, Campagnolo L, Kuhnert F, Stuhlmann H. Egfl7, a novel epidermal growth factor-domain gene expressed in endothelial cells. Dev Dyn 2004;230:316–24.
- Kawedia JD, Yang F, Sartor MA, Gozal D, Czyzyk-Krzeska M, Menon AG. Hypoxia and hypoxia mimetics decrease aquaporin 5 (AQP5) expression through both hypoxia inducible factor-1α and proteasome-mediated pathways. PLoS One 2013;8:e57541.
- Schmidt M, Paes K, De Maziere A, et al. EgfL7 regulates the collective migration of endothelial cells by restricting their spatial distribution. Development 2007;134:2913–23.
- Gerez J, Fuertes M, Tedesco L, et al. In silico structural and functional characterization of the RSUME splice variants. PLoS One 2013;8:e57795.
- Wu F, Yang LY, Li YF, Ou DP, Chen DP, Fan C. Novel role for epidermal growth factor-like domain 7 in metastasis of human hepatocellular carcinoma. Hepatology 2009;50:1839–50.
- Spencer JM. Immune response modifiers and cutaneous neoplasia. Postgrad Med 2002;112:17–21.
- Gustavsson M, Mallard C, Vannucci SJ, Wilson MA, Johnston MV, Hagberg H. Vascular response to hypoxic preconditioning in the immature brain. J Cereb Blood Flow Metab 2007;27:928–38.
- Grundy SM. Cholesterol management in high-risk patients without heart disease. When is lipid-lowering medication warranted for primary revention? Postgrad Med 1998;104:117–20; 123–124, 129.
- Xu D, Perez RE, Ekekezie II, Navarro A, Truog WE. Epidermal growth factor-like domain 7 protects endothelial cells from hyperoxia-induced cell death. Am J Physiol Lung Cell Mol Physiol 2008;294:L17–23.
- Hansen TF, Christensen Rd, Andersen RF, Sørensen FB, Johnsson A, Jakobsen A. MicroRNA-126 and epidermal growth factor-like domain 7-an angiogenic couple of importance in metastatic colorectal cancer. Results from the Nordic ACT trial. Br J Cancer 2013;109:1243–51.
- Ronkainen VP, Ronkainen JJ, Hänninen SL, et al. Hypoxia inducible factor regulates the cardiac expression and secretion of apelin. FASEB J 2007;21:1821–30.
- Zanello M, DeSanctis P, Pula G, et al. Circulating mRNA for epidermal growth factor-like domain 7 (Egfl7) in maternal blood and early intrauterine growth restriction. A preliminary analysis. Prenat Diagn 2013;33:168–72.
- Lee JY, Seo YN, Park HJ, Park YJ, Chung CP. The cell-penetrating peptide domain from human heparin-binding epidermal growth factor-like growth factor (HB-EGF) has anti-inflammatory activity in vitro and in vivo. Biochem Biophys Res Commun 2012;419:597–604.
- Badiwala MV, Guha D, Tumiati L, et al. Epidermal growth factor-like domain 7 is a novel inhibitor of neutrophil adhesion to coronary artery endothelial cells injured by calcineurin inhibition. Circulation 2011;124:S197–203.